Skip to content
2000
Volume 19, Issue 9
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Glutamate has been implicated in the pathogenesis of several diseases on the central nervous system, but recent studies have also suggested that it can be involved also in the onset and course of peripheral neuropathies. Given the increasing evidence of this possibility, several attempts have been performed in order to modulate its activity. Among them, glutamate carboxypeptidase II (GCP II) inhibition demonstrated promising results in different models of peripheral nerve damage, including diabetic and toxic neuropathies

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986712799462694
2012-03-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986712799462694
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test